--- title: "隨着臨牀驗證和生物技術創新重新定義健康，膠原蛋白水解物市場預計到 2036 年將達到 30 億美元" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/277933476.md" description: "全球膠原蛋白水解物市場預計將從 2026 年的 14 億美元增長到 2036 年的 30 億美元，年均增長率為 7.8%。這一增長受到向生物活性肽和發酵衍生替代品轉變的推動，因為消費者對健康益處的臨牀驗證提出了需求。該市場主要由動物來源主導，特別是在營養保健品領域，亞太地區，尤其是中國和日本，增長顯著。主要參與者包括 Gelita AG 和 Rousselot，專注於生物活性成分和可持續實踐" datetime: "2026-03-05T12:18:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277933476.md) - [en](https://longbridge.com/en/news/277933476.md) - [zh-HK](https://longbridge.com/zh-HK/news/277933476.md) --- # 隨着臨牀驗證和生物技術創新重新定義健康，膠原蛋白水解物市場預計到 2036 年將達到 30 億美元 _**Collagen Hydrolysates Market Growth Fueled by Shift Toward Fermentation-Derived Alternatives, Bioactive Peptides, and "Beauty-from-Within" Trends**_ **NEWARK, DE / ACCESS Newswire / March 5, 2026 /** The global collagen hydrolysates sector is undergoing a profound transformation, transitioning from a generic supplement into a scientifically-backed "functional powerhouse" driven by clinical validation and a surge in sustainable biotechnology. According to the latest strategic outlook by Future Market Insights (FMI), the global **Collagen Hydrolysates Market** valued at **USD 1.4 Billion in 2026**\-is projected to reach **USD 3.0 Billion by 2036**, expanding at a robust **7.8% CAGR**. The report identifies a critical pivot: consumers and manufacturers are moving beyond basic gelatin to embrace bioactive, condition-specific peptides that offer targeted benefits for joint mobility, skin elasticity, and gut health. This evolution is spearheaded by a shift toward high-purity extraction technologies and the groundbreaking emergence of non-animal, fermentation-derived alternatives. **Get Access to the Full Report Sample: Explore detailed forecasts, segment insights, and competitive analysis:** https://www.futuremarketinsights.com/reports/sample/rep-gb-14908 **The Pivot to "Clinical Substantiation" and Sustainable Sourcing** A primary driver for this decade-long expansion is the "medicalization" of the supplement aisle. FMI notes that as "beauty-from-within" trends gain mainstream traction, consumers are demanding proof of efficacy. "Collagen is no longer just about marketing hype; it is now a delivery vehicle for proven health outcomes," notes a senior FMI analyst. "We are seeing a massive influx of IP-backed products where clinical trials measuring serum peptide levels are used to justify premium pricing. In early 2025, the FDA's GRAS Notice Inventory confirmation of fermentation-derived collagen has provided a massive regulatory green light for the vegan-friendly sector." **Segment Insights: The Power of Animal-Based Sources and Nutraceutical Dominance** - Animal-Based Segment (65.0% Share): This segment maintains a dominant stronghold due to established global supply chains and the cost-effective availability of Type I and III collagen from bovine and porcine sources. - Nutraceuticals (45.0% Share): Leading the application category, nutraceuticals are fueled by an aging global population seeking preventative measures for joint and bone health. - Powder Formats (48.0% Share): Powder remains the leading form due to its high solubility and versatility in sports nutrition and functional beverages, though gummies and liquid shots are seeing rapid growth in the "lifestyle" category. **Regional Performance: China and Japan Lead the High-Growth Frontier** While North America remains a center for clean-label innovation, the highest velocity of growth is concentrated in the Asia-Pacific region: - China (8.4% CAGR): Leading the global growth curve, China is modernizing its massive manufacturing base to meet international regulatory standards while satisfying surging domestic demand. - Japan (7.9% CAGR): Driven by a sophisticated aesthetic culture and a high elderly population, Japan prioritizes low-molecular-weight peptides with superior absorption rates. - United States (7.5% CAGR): Sustained by the integration of collagen into performance nutrition and the rise of biotech "challenger" brands focused on animal-free alternatives. **Competitive Landscape: IP Protection and Bioactive Ecosystems** The market is characterized by intense competition as legacy gelatin producers transition into "bioactive" ingredient specialists. **Key Players include:** Gelita AG, Rousselot (Darling Ingredients), PB Leiner, Wellnex (Nitta Gelatin Inc.), Geltor, Nippi Collagen, Garden of Life, Orgain, and Viscofan BioEngineering. Strategic highlights include **Rousselot's** recent European patent for its "Colartix" joint health matrix and **Geltor's** focus on "bio-designed" ingredients that allow iconic brands to build sustainable, animal-free products. As Kurt Seidensticker, Founder of Vital Proteins, suggests, "Manufacturing scalability and agility are now prerequisites for capturing mass-market adoption." **Unlock In-Depth Market Intelligence - Access the Full Report Now:** https://www.futuremarketinsights.com/reports/collagen-hydrolysates-market **Why FMI:** https://www.futuremarketinsights.com/why-fmi **Related Reports:** **Pet Cardiovascular Health Supplement Market:** https://www.futuremarketinsights.com/reports/pet-cardiovascular-health-supplement-market **Pet Joint Health Supplements Market:** https://www.futuremarketinsights.com/reports/pet-joint-health-supplements-market **Ready-To-Roll (RTR) Icings Market:** https://www.futuremarketinsights.com/reports/ready-to-roll-rtr-icings-market **Fish-Based Pet Food Market:** https://www.futuremarketinsights.com/reports/fish-based-pet-food-market **Europe Savory Ingredients Market:** https://www.futuremarketinsights.com/reports/europe-savory-ingredients-market **About Future Market Insights (FMI)** Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals. An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities. **For Press & Corporate Inquiries** **Rahul Singh** **AVP - Marketing and Growth Strategy** **Future Market Insights, Inc.** +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/ **SOURCE:** Future Market Insights, Inc. View the original press release on ACCESS Newswire ### 相關股票 - [IBBQ.US](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [DAR.US](https://longbridge.com/zh-HK/quote/DAR.US.md) - [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md) ## 相關資訊與研究 - [鉅亨速報 - Factset 最新調查：阿里拉姆製藥 (ALNY-US) EPS 預估下修至 6.57 元，預估目標價為 447.00 元](https://longbridge.com/zh-HK/news/282708759.md) - [雙雙入選 2026 SGO 口頭報告：蘆康沙妥珠單抗 (sac-TMT) 兩項婦科腫瘤研究成果發佈](https://longbridge.com/zh-HK/news/282607157.md) - [金仕生物自主研發的 ProStyle M®經導管二尖瓣瓣膜系統成功完成全國多中心確證性研究的首例植入](https://longbridge.com/zh-HK/news/282063061.md) - [中慧生物核數師德勤辭任，繼續停牌](https://longbridge.com/zh-HK/news/282607251.md) - [中國三江化工向藍鯨生物能源採購石腦油，年度上限 8800 萬人幣](https://longbridge.com/zh-HK/news/281950036.md)